<DOC>
	<DOCNO>NCT02878291</DOCNO>
	<brief_summary>The purpose study evaluate safety meningococcal ACYW135 polysaccharide conjugate vaccine healthy volunteer age 3 Months</brief_summary>
	<brief_title>Safety Study Meningococcal ACYW135 Polysaccharide Conjugate Vaccine Healthy Volunteers Aged Above 3 Months</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>311 month health infant n't immuned Meningococcal A C Conjugate Vaccine population 1 year old have't give boost immunity . Subject legal representative consent sign write informed consent . Subject did't immune live vaccine within 14 day inactivate vaccine within 7 day vaccination . Subject parent/guardian able comply study procedure . Axillary temperature ≤37.0 ℃ . History allergy，eclampsia , epilepsy , encephalopathy mental disease family disease . Allergic history vaccination . History meningitis infection disease . Acute Febrile illness Infectious Diseases . Febrile illness ( temperature ≥ 38°C ) 3 day . Immunodeficiency diseases patient administer immunosuppressive agent . Children within 1 year old abnormal labor , asphyxia rescue history , congenital malformation , genetic defect , eccyliosis severe chronic disease . Liver kidney cardiopulmonary disease，acute hypertension diabetes . In pregnancy lactation pregnant woman . Subject plan participate drug clinical trial . Meningococcal vaccine contraindication . Any condition , judgment investigator , may affect trial assessment .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>